Aarkstore Enterprise-Thalassemia – Pipeline Review, H1 2012 || Aarkstore.com by aarks222


More Info
									Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Thalassemia – Pipeline Review, H1 2012


RSS link of Global Markets Direct


Global Markets Direct’s, Thalassemia - Pipeline Review, H1 2012, provides an
overview of the Thalassemia therapeutic pipeline. This report provides information
on the therapeutic development for Thalassemia, complete with latest updates, and
special features on late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Thalassemia. Thalassemia - Pipeline
Review, H1 2012 is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.


- A snapshot of the global therapeutic scenario for Thalassemia.
- A review of the Thalassemia products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined

Table of contents:

List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Thalassemia Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Thalassemia 8
Thalassemia Therapeutics under Development by Companies 10
Thalassemia Therapeutics under Investigation by Universities/Institutes 11
Late Stage Products 13
Comparative Analysis 13
Mid Clinical Stage Products 14
Comparative Analysis 14
Early Clinical Stage Products 15
Comparative Analysis 15
Pre-Clinical Stage Products 16
Comparative Analysis 16
Thalassemia Therapeutics – Products under Development by Companies 17
Thalassemia Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in Thalassemia Therapeutics Development 19
Gamida Cell Ltd. 19
HemaQuest Pharmaceuticals, Inc. 20
GENETIX Pharmaceuticals, Inc. 21
Acetylon Pharmaceuticals, Inc. 22
Emmaus Medical, Inc. 23
Errant Gene Therapeutics, LLC 24
Thalassemia – Therapeutics Assessment 25
Assessment by Monotherapy Products 25
Assessment by Combination Products 26
Assessment by Route of Administration 27
List of Figures

List of Tables are also include.

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1

Thrombosis – Pipeline Review, H1 2012

Aplastic Anemia – Pipeline Review, H1 2012

Xerostomia – Pipeline Review, H1 2012

Congestive Heart Failure (Heart Failure) – Pipeline Review, H1 2012

Thalassemia – Pipeline Review, H1 2012

Bacterial Vaginosis – Pipeline Review, H1 2012

Chemotherapy Induced Peripheral Neuropathy – Pipeline Review, H1 2012

Gliosarcoma – Pipeline Review, H1 2012

Nicotine Addiction – Pipeline Review, H1 2012

Hemorrhage – Pipeline Review, H1 2012

Insulin Resistance – Pipeline Review, H1 2012
Adenovirus Infections – Pipeline Review, H1 2012

Abscess – Pipeline Review, H1 2012

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and

You can also request for sample page of above mention reports on

For More details Plz do contact :

Aarkstore Enterprise



Email: enquiry@aarkstore.com

To top